Cited by 209Wnt/β-catenin signaling in development and cancerDevelopmental Biology and Gene RegulationCancer Cells and Metastasis

β-Catenin and Tcfs in Mammary Development and Cancer

Hatsell, Sarah, Rowlands, Tracey, Hiremath, Minoti, Cowin, Pamela·2003·Journal of Mammary Gland Biology and Neoplasia

Abstract

Beta-catenin regulates cell-cell adhesion and transduces signals from many pathways to regulate the transcriptional activities of Tcf/Lef DNA binding factors. Gene ablation and transgenic expression studies strongly support the concept that beta-catenin together with Lef/Tcf factors act as a switch to determine cell fate and promote cell survival and proliferation at several stages during mammary gland development. Mice expressing the negative regulator of Wnt/beta-catenin signaling (K14-Dkk) fail to form mammary buds, and those lacking Lef-1 show an early arrest in this process at stage E13.5. Stabilized deltaN89beta-catenin initiates precocious alveologenesis during pubertal development, and negative regulators of endogenous beta-catenin signaling suppress normal alveologenesis during pregnancy. Stabilized beta-catenin induces hyperplasia and mammary tumors in mice. Each of the beta-catenin-induced phenotypes is accompanied by upregulation of the target genes cyclin D1 and c-myc. Cyclin D1, however, is dispensable for tumor formation and the initiation of alveologenesis but is essential for later alveolar expansion.

Integrity signals

Registry

Crossref · 10.1023/a:1025944723047

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Once Dsh is activated, it inhibits the activity of the GSK3 enzyme, and activates a complex series of events that lead to the prevention of degradation of β-catenin and its consequent stabilization and accumulation in the cytoplasm.

    “Once Dsh is activated, it inhibits the activity of the GSK3 enzyme, and activates a complex series of events that lead to the prevention of degradation of β-catenin and its consequent stabilization and accumulation in the cytoplasm.42”

    From Wnt signal transduction pathways (2008) · cites this paper as [42]

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hatsell, S., Rowlands, T., Hiremath, M., & Cowin, P.
Affiliations
New York University (US)
Corresponding author
Cowin, Pamela
Venue
Journal of Mammary Gland Biology and Neoplasia
Published
2003-04
Volume
8
Issue
2
Pages
145-158
ISSN
  • 1083-3021 (ISSN-L)
  • 1573-7039
OpenAlex
W1520332974
Cited by
209
References
93
Citations by year
2025: 2 · 2024: 9 · 2023: 7 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 11 · 2016: 3 · 2015: 14 · 2014: 10 · 2013: 7 · 2012: 10
FWCI
1.09
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Mammary Gland Biology and Neoplasia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Health Research Board
  • National Institute for Health and Care Research
  • National Institutes of Health
  • National Institute of General Medical Sciences (GM 47429, R01GM047429)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
β-catenin, TCF/LEF transcription factors, mammary gland development, breast cancer, Wnt/β-catenin signaling, alveolarization, cyclin D1, c-Myc, cell fate determination, mammary gland hyperplasia, LEF1, alveolar expansion
MeSH terms
Animals, Breast Neoplasms, Cell Adhesion, Cell Division, Cell Survival, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Humans, Mammary Glands, Animal, Models, Biological, Phenotype, Transcription Factors, Signal Transduction, Trans-Activators, Mammary Neoplasms, Animal, Cadherins, Up-Regulation, Proto-Oncogene Proteins c-myc, Mucin-1, Cyclin D1, Mammary Glands, Human, beta Catenin, Mice, Lymphoid Enhancer-Binding Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review